You are here:
Healthcare Brands — OTC & Consumer Health Ownership
Last Updated:February 24, 2026
About This Investor
JP-B-289
Budget guidance is $6.54M – $32.7M. From Japan, they are evaluating both investment and acquisition structures depending on the case. Priority theme: Businesses that handle OTC drugs (i.e., have OTC brands) Businesses that own healthcare product brands. They are prioritizing Priority countries: Thailand, Singapore, Malaysia, Vietnam, Indonesia, Philippines Countries eligible for consideration: Asia. Majority ownership…
Healthcare (OTC / Consumer Health)
Asia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam
Strategic Synergy
$6.54M - $32.7M
Majority (principle) | Minority (initial) possible
Request Full Investor Profile
Similar Investors
JP-B-162
With roots in Japan, they are seeking targets that match
Renewable Energy (Biomass)
ASEAN, India
New Business Development
$3.27M - $32.7Mc
Minority / Majority / 100%
JP-B-507
Search focus: From Japan, this investor is open to qualified
Food Manufacturing (Bakery/Confectionery)
ASEAN, Europe, India, USA
Overseas Expansion
$3.27M - $13.1M
Minority
JP-B-592
From Japan, they are seeking targets that match the following
Media Technology
Worldwide
Overseas Expansion
$654K - $6.54M
100%/Majority | Minority possible if synergy + step-up control feasible